Clinical trial
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small…
NCT00124618 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00124618 |
|---|---|
| Title | Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer |
| Official title | Cetuximab (C225) and Radiation in Elderly and /or Poor Performance Status Patients With Locally Advanced Non-Small Cell Lung Cancer: A Phase II Study to Evaluate Survival and Toxicity |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Radiation |
| Interventions | cetuximab, radiation therapy |
| Enrollment | 58 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Mar 1, 2015 |
| First posted | Jul 28, 2005 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: